Ampio Announces Results Of The Open Label Portion Of The Multiple Intra-articular Injections Study Of Ampion In Patients With Osteoarthritis Of The Knee At Week Twenty Of The Trial
December 01, 2014 at 08:03 AM EST
Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced updates for the STRUT open label portion (n=7) of the multiple injection ...
